e-Prime: Advances in Electrical Engineering, Electronics and Energy (Sep 2024)
Diagnosing the MRI brain tumour images through RNN-LSTM
Abstract
According to the World Health Organization, cancer is the second most common cause of death worldwide (WHO). Death from cancer may sometimes be avoided through early diagnosis, although this is not always practicable. A tumour, unlike cancer, may be benign, pre-cancerous, or malignant. Contrary to malignant tumours, benign tumours may frequently be surgically removed and seldom metastasize to other organs or tissues. The method most often used to differentiate between various types of tumours is magnetic resonance imaging (MRI) (MRI). But because it depends on human subjectivity, it could be challenging for one person to see a lot of data. The radiologist's ability to identify brain tumours early mostly depends on their level of training. Before determining whether the tumour is benign or malignant, the diagnostic process for it could not be finished. A biopsy is often carried out to determine if the tissue is benign or cancerous. The biopsy of a brain tumour is often delayed until the last brain operation, in contrast to tumours discovered elsewhere in the body. An efficient diagnostics tool for tumour segmentation and classification from MRI images is crucial to obtaining accurate diagnoses, avoiding surgery, and eliminating subjectivity. The classification and segmentation of the tumour part of the MRI brain picture is the goal of this study. Prior to feature extraction in the first study, pre-processing is done using the Gray Level Co-occurrence Matrix (GLCM). Based on these features, the data is then separated into normal, glioma, meningioma, and pituitary groups. In prior studies, classification was handled by traditional Deep Neural Networks (DNN), with the best weights selected using optimization methods. Accordingly, a recent study recommends including Long Short-Term Memory based on Recurrent Neural Networks (RNN) (LSTM). The Local Direction Ternary Pattern (LDTP), the Gray Level Co-occurrence Matrix (GLCM), and the Le-Net features are all combined in the proposed Hybrid GLCM-LDTP-Le-Net Feature extraction approach. The hybrid parameters produced by the feature extraction process and the brain MRI data are used by the RNN-LSTM model to categorise the data as benign or malignant. By removing mixed features from the input data, the suggested hybrid feature extraction improves the learnt models' accuracy. The accuracy of 98.99 % of the suggested hybrid feature extraction approach was higher than the current CNN-based model methodologies.
